Eerdekens, Mariëlle
Johnson & Johnson Pharmaceutical Research and Development, Beerse, Belgium
3 papers on CoChatORCID 0000-0001-6198-4806
Most cited papers
- Verified
Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol
Smulevich, A. B., Khanna, S., Eerdekens, M., Karcher, K., Kramer, M., & Grossman, F. (2005) · European Neuropsychopharmacology
Bipolar Disorder and TreatmentSchizophrenia research and treatment
Cited by 192
- Verified
Pharmacokinetics and D2 receptor occupancy of long-acting injectable risperidone (Risperdal Consta™) in patients with schizophrenia
Gefvert, O., Eriksson, B., Persson, P., Helldin, L., Björner, A., Mannaert, E., Remmerie, B., Eerdekens, M., & Nyberg, S. (2005) · The International Journal of Neuropsychopharmacology
Schizophrenia research and treatmentNeurotransmitter Receptor Influence on Behavior
Cited by 119
- Verified
A comparison of serum prolactin concentrations after administration of paliperidone extended-release and risperidone tablets in patients with schizophrenia
Berwaerts, J., Cleton, A., Rossenu, S., Talluri, K., Remmerie, B., Janssens, L., Boom, S., Kramer, M., & Eerdekens, M. (2010) · Journal of Psychopharmacology
Schizophrenia research and treatmentPharmacogenetics and Drug Metabolism
Cited by 49
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free